{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:31:35Z","timestamp":1782192695730,"version":"3.54.5"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T00:00:00Z","timestamp":1257811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/nrclinonc.2009.169","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T04:50:05Z","timestamp":1257828605000},"page":"707-717","source":"Crossref","is-referenced-by-count":143,"title":["Gamma-delta T-cell lymphomas"],"prefix":"10.1038","volume":"6","author":[{"given":"Claudio","family":"Tripodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Iannitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada Maria","family":"Florena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Ennio","family":"Pucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Aldo","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,10]]},"reference":[{"key":"BFnrclinonc2009169_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Armitage","year":"2008","unstructured":"Armitage, J., Vose, J. & Weisenburger, D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2009169_CR2","volume-title":"World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow, S. H et al. (eds) World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (IARC, Lyon, 2008)."},{"key":"BFnrclinonc2009169_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga, P. P. et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J. Clin. Invest. 117, 823\u2013834 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrclinonc2009169_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/jcp.2008.055335","volume":"61","author":"C Agostinelli","year":"2008","unstructured":"Agostinelli, C. et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J. Clin. Pathol. 61, 1160\u20131167 (2008).","journal-title":"J. Clin. Pathol."},{"key":"BFnrclinonc2009169_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2006.05.010","volume":"25","author":"M Ciofani","year":"2006","unstructured":"Ciofani, M., Knowles, G. C., Wiest, D. L., von Boehmer, H. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. Stage-specific and differential Notch dependency at the \u03b1\u03b2 and \u03b3\u03b4 T lineage bifurcation. Immunity 25, 105\u2013116 (2006).","journal-title":"Immunity"},{"key":"BFnrclinonc2009169_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-2712(18)30694-2","volume":"8","author":"SM Denning","year":"1988","unstructured":"Denning, S. M. & Haynes, B. F. Differentiation of human T cells. Clin. Lab. Med. 8, 1\u201314 (1988).","journal-title":"Clin. Lab. Med."},{"key":"BFnrclinonc2009169_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0952-7915(94)90125-2","volume":"6","author":"WL Havran","year":"1994","unstructured":"Havran, W. L. & Boismenu, R. Activation and function of \u03b3\u03b4 T cells. Curr. Opin. Immunol. 6, 442\u2013446 (1994).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrclinonc2009169_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4049\/jimmunol.166.2.765","volume":"166","author":"TJ Sayers","year":"2001","unstructured":"Sayers, T. J. et al. The restricted expression of granzyme M in human lymphocytes. J. Immunol. 166, 765\u2013771 (2001).","journal-title":"J. Immunol."},{"key":"BFnrclinonc2009169_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1189\/jlb.0208107","volume":"85","author":"PK Chattopadhyay","year":"2009","unstructured":"Chattopadhyay, P. K. et al. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85, 88\u201397 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrclinonc2009169_CR10","first-page":"357","volume":"136","author":"G Inghirami","year":"1990","unstructured":"Inghirami, G., Zhu, B. Y., Chess, L. & Knowles, D. M. Flow cytometric and immunohistochemical characterization of the \u03b3\/\u03b4 T-lymphocyte population in normal human lymphoid tissue and peripheral blood. Am. J. Pathol. 136, 357\u2013367 (1990).","journal-title":"Am. J. Pathol."},{"key":"BFnrclinonc2009169_CR11","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.4049\/jimmunol.143.8.2480","volume":"143","author":"B Falini","year":"1989","unstructured":"Falini, B. et al. Distribution of T cells bearing different forms of the T cell receptor \u03b3\/\u03b4 in normal and pathological human tissues. J. Immunol. 143, 2480\u20132488 (1989).","journal-title":"J. Immunol."},{"key":"BFnrclinonc2009169_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-065X.2006.00472.x","volume":"215","author":"B Moser","year":"2007","unstructured":"Moser, B. & Eberl, M. \u03b3\u03b4 T cells: novel initiators of adaptive immunity. Immunol. Rev. 215, 89\u2013102 (2007).","journal-title":"Immunol. Rev."},{"key":"BFnrclinonc2009169_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh, V., Steinle, A., Bauer S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial \u03b3\u03b4 T cells. Science 279, 1737\u20131740 (1998).","journal-title":"Science"},{"key":"BFnrclinonc2009169_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human \u03b3\u03b4 T cells. Science 309, 264\u2013268 (2005).","journal-title":"Science"},{"key":"BFnrclinonc2009169_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0092-8674(94)90170-8","volume":"76","author":"H Schild","year":"1994","unstructured":"Schild, H. et al. The nature of major histocompatibility complex recognition by \u03b3\u03b4 T cells. Cell 76, 29\u201337 (1994).","journal-title":"Cell"},{"key":"BFnrclinonc2009169_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-065X.2006.00470.x","volume":"215","author":"YH Chien","year":"2007","unstructured":"Chien, Y. H. & Konigshofer, Y. Antigen recognition by \u03b3\u03b4 T cells. Immunol. Rev. 215, 46\u201358 (2007).","journal-title":"Immunol. Rev."},{"key":"BFnrclinonc2009169_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2008-06-162792","volume":"113","author":"G Gong","year":"2009","unstructured":"Gong, G. et al. Phosphoantigen-activated V\u03b3 2V\u03b4 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection. Blood 113, 837\u2013845 (2009).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR18","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","volume":"178","author":"K Shibata","year":"2007","unstructured":"Shibata, K., Yamada, H., Hara, H., Kishihara, K. & Yoshikai, Y. Resident V\u03b41+ \u03b3\u03b4 T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466\u20134472 (2007).","journal-title":"J. Immunol."},{"key":"BFnrclinonc2009169_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1189\/jlb.0404219","volume":"76","author":"B Toth","year":"2004","unstructured":"Toth, B. et al. The role of \u03b3\u03b4 T cells in the regulation of neutrophil-mediated tissue damage after thermal injury. J. Leukoc. Biol. 76, 545\u2013552 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrclinonc2009169_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.immuni.2008.04.022","volume":"29","author":"KD Jensen","year":"2008","unstructured":"Jensen, K. D. Thymic selection determines \u03b3\u03b4 T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon \u03b3. Immunity 29, 90\u2013100 (2008).","journal-title":"Immunity"},{"key":"BFnrclinonc2009169_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","volume":"2","author":"GK Przybylski","year":"2000","unstructured":"Przybylski, G. K. et al. Hepatosplenic and subcutaneous panniculitis-like \u03b3\/\u03b4 T cell lymphomas are derived from different V\u03b4 subsets of \u03b3\/\u03b4 T lymphocytes. J. Mol. Diagn. 2, 11\u201319 (2000).","journal-title":"J. Mol. Diagn."},{"key":"BFnrclinonc2009169_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ajh.21062","volume":"83","author":"SK Tey","year":"2008","unstructured":"Tey, S. K., Marlton, P. V., Hawley, C. M., Norris, D. & Gill, D. S. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen. Am. J. Hematol. 83, 330\u2013333 (2008).","journal-title":"Am. J. Hematol."},{"key":"BFnrclinonc2009169_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC","volume":"116","author":"WA Khan","year":"2001","unstructured":"Khan, W. A. et al. Hepatosplenic \u03b3\/\u03b4 T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature. Am. J. Clin. Pathol. 116, 41\u201350 (2001).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrclinonc2009169_CR24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","volume":"85","author":"DM Knowles","year":"1995","unstructured":"Knowles, D. M. et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85, 552\u2013565 (1995).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V72.3.841.bloodjournal723841","volume":"72","author":"E Vilmer","year":"1988","unstructured":"Vilmer, E. et al. Prominent expansion of circulating lymphocytes bearing \u03b3 T-cell receptors, with preferential expression of variable \u03b3 genes after allogeneic bone marrow transplantation. Blood 72, 841\u2013849 (1988).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.2006.00489.x","volume":"215","author":"M Kronenberg","year":"2007","unstructured":"Kronenberg, M. & Havran, W. L. Frontline T cells: \u03b3\u03b4 T cells and intraepithelial lymphocytes. Immunol. Rev. 215, 5\u20137 (2007).","journal-title":"Immunol. Rev."},{"key":"BFnrclinonc2009169_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ajcp\/102.3.310","volume":"102","author":"CW Ross","year":"1994","unstructured":"Ross, C. W., Schnitzer, B., Sheldon, S., Braun, D. K. & Hanson, C. A. \u03b3\/\u03b4 T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am. J. Clin. Pathol. 102, 310\u2013315 (1994).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrclinonc2009169_CR28","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj, K. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102, 4261\u20134269 (2003).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","volume":"44","author":"AC Mackey","year":"2007","unstructured":"Mackey, A. C., Green, L., Liang, L. C., Dinndorf, P. & Avigan, M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 44, 265\u2013267 (2007).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrclinonc2009169_CR30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/gut.2008.163279","volume":"57","author":"M Shale","year":"2008","unstructured":"Shale, M., Kanfer, E., Panaccione, R. & Ghosh, S. Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut 57, 1639\u20131641 (2008).","journal-title":"Gut"},{"key":"BFnrclinonc2009169_CR31","unstructured":"US Food and Drug Administration The Adverse Event Reporting System (AERS): Latest Quarterly Data Files [ online ], (2009)."},{"key":"BFnrclinonc2009169_CR32","first-page":"1024","volume":"136","author":"JR Toro","year":"2000","unstructured":"Toro, J. R. et al. \u03b3 \u03b4 T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch. Dermatol. 136, 1024\u20131032 (2000).","journal-title":"Arch. Dermatol."},{"key":"BFnrclinonc2009169_CR33","first-page":"1723","volume":"91","author":"B Arnulf","year":"1998","unstructured":"Arnulf, B. et al. Nonhepatosplenic \u03b3\u03b4 T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 91, 1723\u20131731 (1998).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR34","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","volume":"75","author":"JP Farcet","year":"1990","unstructured":"Farcet, J. P. et al. Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor \u03b3 \u03b4. Blood 75, 2213\u20132219 (1990).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0037-1963(03)00137-9","volume":"40","author":"P Gaulard","year":"2003","unstructured":"Gaulard, P., Belhadj, K. & Reyes, F. \u03b3\u03b4 T-cell lymphomas. Semin. Hematol. 40, 233\u2013243 (2003).","journal-title":"Semin. Hematol."},{"key":"BFnrclinonc2009169_CR36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","volume":"20","author":"GS Falchook","year":"2009","unstructured":"Falchook, G. S. et al. Hepatosplenic \u03b3-\u03b4 T-cell lymphoma: clinicopathological features and treatment. Ann. Oncol. 20, 1080\u20131085 (2009).","journal-title":"Ann. Oncol."},{"key":"BFnrclinonc2009169_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.leu.2401784","volume":"14","author":"E Weidmann","year":"2000","unstructured":"Weidmann, E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14, 991\u2013997 (2000).","journal-title":"Leukemia"},{"key":"BFnrclinonc2009169_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00428-002-0661-6","volume":"441","author":"AM Florena","year":"2002","unstructured":"Florena, A. M., Iannitto, E., Quintini, G. & Franco, V. Bone marrow biopsy in hemophagocytic syndrome. Virchows Arch. 441, 335\u2013344 (2002).","journal-title":"Virchows Arch."},{"key":"BFnrclinonc2009169_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJM199110103251506","volume":"325","author":"G Burg","year":"1991","unstructured":"Burg, G. et al. A subcutaneous \u03b4-positive T-cell lymphoma that produces interferon \u03b3. N. Engl. J. Med. 325, 1078\u20131081 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2009169_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L","volume":"60","author":"A Nosari","year":"1999","unstructured":"Nosari, A. et al. Hepato-splenic \u03b3\u03b4 T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am. J. Hematol. 60, 61\u201365 (1999).","journal-title":"Am. J. Hematol."},{"key":"BFnrclinonc2009169_CR41","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier, K. et al. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106, 3483\u20133489 (2005).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-4362.1996.tb01606.x","volume":"35","author":"CY Wang","year":"1996","unstructured":"Wang, C. Y., Su, W. P. & Kurtin, P. J. Subcutaneous panniculitic T-cell lymphoma. Int. J. Dermatol. 35, 1\u20138 (1996).","journal-title":"Int. J. Dermatol."},{"key":"BFnrclinonc2009169_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","volume":"29","author":"S Kumar","year":"1998","unstructured":"Kumar, S. et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum. Pathol. 29, 397\u2013403 (1998).","journal-title":"Hum. Pathol."},{"key":"BFnrclinonc2009169_CR44","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","volume":"101","author":"JR Toro","year":"2003","unstructured":"Toro, J. R. et al. \u03b3-\u03b4 T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 101, 3407\u20133412 (2003).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR45","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","volume":"111","author":"R Willemze","year":"2008","unstructured":"Willemze, R. et al. EORTC Cutaneous Lymphoma Group. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111, 838\u2013845 (2008).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR46","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","volume":"127","author":"F Vega","year":"2007","unstructured":"Vega, F., Medeiros, L. J. & Gaulard, P. Hepatosplenic and other \u03b3\u03b4 T-cell lymphomas. Am. J. Clin. Pathol. 127, 869\u2013880 (2007).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrclinonc2009169_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0046-8177(97)90176-3","volume":"28","author":"KE Salhany","year":"1997","unstructured":"Salhany, K. E. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum. Pathol. 28, 674\u2013685 (1997).","journal-title":"Hum. Pathol."},{"key":"BFnrclinonc2009169_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s002770050272","volume":"74","author":"S Sallah","year":"1997","unstructured":"Sallah, S. et al. \u03b3\/\u03b4 T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Ann. Hematol. 74, 139\u2013142 (1997).","journal-title":"Ann. Hematol."},{"key":"BFnrclinonc2009169_CR49","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V74.7.2501.2501","volume":"74","author":"B Falini","year":"1989","unstructured":"Falini, B. et al. T-lymphoblastic lymphomas expressing the non-disulfide-linked form of the T-cell receptor \u03b3\/\u03b4: characterization with monoclonal antibodies and genotypic analysis. Blood 74, 2501\u20132507 (1989).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1023\/A:1008349422735","volume":"10","author":"S Ascani","year":"1999","unstructured":"Ascani, S. et al. T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature. Ann. Oncol. 10, 649\u2013653 (1999).","journal-title":"Ann. Oncol."},{"key":"BFnrclinonc2009169_CR51","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","volume":"28","author":"C Massone","year":"2004","unstructured":"Massone, C. et al. Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am. J. Surg. Pathol. 28, 719\u2013735 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrclinonc2009169_CR52","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/cncr.20502","volume":"101","author":"RS Go","year":"2004","unstructured":"Go, R. S. & Wester, S. M. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer 101, 1404\u20131413 (2004).","journal-title":"Cancer"},{"key":"BFnrclinonc2009169_CR53","first-page":"617","volume":"137","author":"P Gaulard","year":"1990","unstructured":"Gaulard, P. et al. Expression of the \u03b1\/\u03b2 and \u03b3\/\u03b4 T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of \u03b3\/\u03b4 T-cell lymphomas. Am. J. Pathol. 137, 617\u2013628 (1990).","journal-title":"Am. J. Pathol."},{"key":"BFnrclinonc2009169_CR54","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","volume":"88","author":"CB Cooke","year":"1996","unstructured":"Cooke, C. B. et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic \u03b3 \u03b4 T-cell origin. Blood 88, 4265\u20134274 (1996).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1365-2559.2000.00893.x","volume":"36","author":"C de Wolf-Peeters","year":"2000","unstructured":"de Wolf-Peeters, C. & Achten, R. \u03b3\u03b4 T-cell lymphomas: a homogeneous entity? Histopathology 36, 294\u2013305 (2000).","journal-title":"Histopathology"},{"key":"BFnrclinonc2009169_CR56","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/00000478-200107000-00004","volume":"25","author":"Y Allory","year":"2001","unstructured":"Allory, Y. et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am. J. Surg. Pathol. 25, 865\u2013874 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrclinonc2009169_CR57","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hep.1840060510","volume":"6","author":"P Gaulard","year":"1986","unstructured":"Gaulard, P. et al. Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology 6, 864\u2013868 (1986).","journal-title":"Hepatology"},{"key":"BFnrclinonc2009169_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/10428190500272556","volume":"47","author":"AM Florena","year":"2006","unstructured":"Florena, A. M. et al. Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement. Leuk. Lymphoma 47, 49\u201357 (2006).","journal-title":"Leuk. Lymphoma"},{"key":"BFnrclinonc2009169_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0046-8177(94)90179-1","volume":"25","author":"S Mastovich","year":"1994","unstructured":"Mastovich, S., Ratech, H., Ware, R. E., Moore, J. O. & Borowitz, M. J. Hepatosplenic T-cell lymphoma: an unusual case of a \u03b3 \u03b4 T-cell lymphoma with a blast-like terminal transformation. Hum. Pathol. 25, 102\u2013108 (1994).","journal-title":"Hum. Pathol."},{"key":"BFnrclinonc2009169_CR60","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","volume":"116","author":"F Vega","year":"2001","unstructured":"Vega, F. et al. Hepatosplenic \u03b3\/\u03b4 T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am. J. Clin. Pathol. 116, 410\u2013419 (2001).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrclinonc2009169_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4","volume":"183","author":"ML Boulland","year":"1997","unstructured":"Boulland, M. L., Kanavaros, P., Wechsler, J., Casiraghi, O. & Gaulard, P. Cytotoxic protein expression in natural killer cell lymphomas and in \u03b1 \u03b2 and \u03b3 \u03b4 peripheral T-cell lymphomas. J. Pathol. 183, 432\u2013439 (1997).","journal-title":"J. Pathol."},{"key":"BFnrclinonc2009169_CR62","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","volume":"24","author":"F Suarez","year":"2000","unstructured":"Suarez, F. et al. Hepatosplenic \u03b1\u03b2 T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of \u03b3\u03b4 hepatosplenic T-cell lymphoma. Am. J. Surg. Pathol. 24, 1027\u20131032 (2000).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrclinonc2009169_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","volume":"25","author":"WR Macon","year":"2001","unstructured":"Macon, W. R. Hepatosplenic \u03b1\u03b2 T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic \u03b3\u03b4 T-cell lymphomas. Am. J. Surg. Pathol. 25, 285\u2013296 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrclinonc2009169_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/gcc.2870120302","volume":"12","author":"CC Wang","year":"1995","unstructured":"Wang, C. C. et al. Consistent presence of isochromosome 7q in hepatosplenic T \u03b3\/\u03b4 lymphoma: a new cytogenetic-clinicopathologic entity. Genes Chromosomes Cancer 12, 161\u2013164 (1995).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrclinonc2009169_CR65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/gcc.10021","volume":"33","author":"I Wlodarska.","year":"2002","unstructured":"Wlodarska. I. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 33, 243\u2013251 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrclinonc2009169_CR66","first-page":"1453","volume":"10","author":"P Jonveaux","year":"1996","unstructured":"Jonveaux, P., Daniel, M. T., Martel, V., Maarek, O. & Berger, R. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T \u03b3\/\u03b4 lymphoma. Leukemia 10, 1453\u20131455 (1996).","journal-title":"Leukemia"},{"key":"BFnrclinonc2009169_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00428-006-0267-5","volume":"449","author":"J Tamaska","year":"2006","unstructured":"Tamaska, J. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Virchows Arch. 449, 479\u2013483 (2006).","journal-title":"Virchows Arch."},{"key":"BFnrclinonc2009169_CR68","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","volume":"11","author":"EL Alonsozana","year":"1997","unstructured":"Alonsozana, E. L. et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic \u03b3\u03b4 T cell lymphoma. Leukemia 11, 1367\u20131372 (1997).","journal-title":"Leukemia"},{"key":"BFnrclinonc2009169_CR69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","volume":"113","author":"K Miyazaki","year":"2009","unstructured":"Miyazaki, K. et al. Gene expression profiling of peripheral T-cell lymphoma including \u03b3\u03b4 T-cell lymphoma. Blood 113, 1071\u20131074 (2009).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2141.2000.02129.x","volume":"110","author":"D Aldinucci","year":"2000","unstructured":"Aldinucci, D. et al. In vitro and in vivo effects of 2\u2032-deoxycoformycin (Pentostatin) on tumour cells from human \u03b3\u03b4+ T-cell malignancies. Br. J. Haematol. 110, 188\u2013196 (2000).","journal-title":"Br. J. Haematol."},{"key":"BFnrclinonc2009169_CR71","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","volume":"117","author":"E Iannitto","year":"2002","unstructured":"Iannitto, E., Barbera, V., Quintini, G., Cirrincione, S. & Leone, M. Hepatosplenic \u03b3\u03b4 T-cell lymphoma: complete response induced by treatment with pentostatin. Br. J. Haematol. 117, 995\u2013996 (2002).","journal-title":"Br. J. Haematol."},{"key":"BFnrclinonc2009169_CR72","first-page":"ECR14","volume":"90","author":"G Corazzelli","year":"2005","unstructured":"Corazzelli, G. et al. Pentostatin (2\u2032-deoxycoformycin) for the treatment of hepatosplenic \u03b3\u03b4 T-cell lymphomas. Haematologica 90, ECR14 (2005).","journal-title":"Haematologica"},{"key":"BFnrclinonc2009169_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.imlet.2007.04.014","volume":"111","author":"P Macor","year":"2007","unstructured":"Macor, P. & Tedesco, F. Complement as effector system in cancer immunotherapy. Immunol. Lett. 111, 6\u201313 (2007).","journal-title":"Immunol. Lett."},{"key":"BFnrclinonc2009169_CR74","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.1158\/0008-5472.CAN-07-1811","volume":"67","author":"P Macor","year":"2007","unstructured":"Macor, P. et al. In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. Cancer Res. 67, 10556\u201310563 (2007).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2009169_CR75","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini, A. et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 110, 2316\u20132323 (2007).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR76","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","volume":"76","author":"S Mittal","year":"2006","unstructured":"Mittal, S., Milner, B. J., Johnston, P. W. & Culligan, D. J. A case of hepatosplenic \u03b3-\u03b4 T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur. J. Haematol. 76, 531\u2013534 (2006).","journal-title":"Eur. J. Haematol."},{"key":"BFnrclinonc2009169_CR77","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","volume":"19","author":"G Jaeger","year":"2008","unstructured":"Jaeger, G. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. Ann. Oncol. 19, 1025\u20131026 (2008).","journal-title":"Ann. Oncol."},{"key":"BFnrclinonc2009169_CR78","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.4049\/jimmunol.181.9.5857","volume":"181","author":"M Ferrarini","year":"2008","unstructured":"Ferrarini, M. et al. NF-\u03baB modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human \u03b3 \u03b4 lymphocytes. J. Immunol. 181, 5857\u20135864 (2008).","journal-title":"J. Immunol."},{"key":"BFnrclinonc2009169_CR79","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/eji.200838741","volume":"39","author":"C Koenecke","year":"2009","unstructured":"Koenecke, C. et al. In vivo application of mAb directed against the \u03b3\u03b4 TCR does not deplete but generates \u201cinvisible\u201d \u03b3\u03b4 T cells. Eur. J. Immunol. 39, 372\u2013379 (2009).","journal-title":"Eur. J. Immunol."},{"key":"BFnrclinonc2009169_CR80","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3816\/CLM.2007.n.040","volume":"7","author":"T Hathaway","year":"2007","unstructured":"Hathaway, T., Subtil, A., Kuo, P. & Foss, F. Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma. Clin. Lymphoma Myeloma 7, 541\u2013545 (2007).","journal-title":"Clin. Lymphoma Myeloma"},{"key":"BFnrclinonc2009169_CR81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3816\/CLM.2008.n.005","volume":"8","author":"K Vidulich","year":"2008","unstructured":"Vidulich, K., Jones, D. & Duvic, M. Cutaneous \u03b3\/\u03b4 T-cell lymphoma treated with radiation and denileukin diftitox. Clin. Lymphoma Myeloma 8, 55\u201358 (2008).","journal-title":"Clin. Lymphoma Myeloma"},{"key":"BFnrclinonc2009169_CR82","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2005-09-3581","volume":"107","author":"CS Bonder","year":"2006","unstructured":"Bonder, C. S., Clark, S. R., Norman, M. U., Johnson, P & Kubes, P. Use of CD44 by CD4+ TH1 and TH2 lymphocytes to roll and adhere. Blood 107, 4798\u20134806 (2006).","journal-title":"Blood"},{"key":"BFnrclinonc2009169_CR83","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.coi.2006.07.002","volume":"18","author":"M Bonneville","year":"2006","unstructured":"Bonneville, M. & Scotet, E. Human V\u03b39V\u03b42 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 18, 539\u2013546 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrclinonc2009169_CR84","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-07-4912","volume":"14","author":"AA Alexander","year":"2008","unstructured":"Alexander, A. A. et al. Isopentenyl pyrophosphate-activated CD56+ \u03b3\u03b4 T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin. Cancer Res. 14, 4232\u20134240 (2008).","journal-title":"Clin. Cancer Res."},{"key":"BFnrclinonc2009169_CR85","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.4049\/jimmunol.0803068","volume":"182","author":"A Thedrez","year":"2009","unstructured":"Thedrez, A. et al. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V\u03b3 9V \u03b42 T cells for adoptive immunotherapy. J. Immunol. 182, 3423\u20133431 (2009).","journal-title":"J. Immunol."},{"key":"BFnrclinonc2009169_CR86","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/eji.200838812","volume":"39","author":"L Martinet","year":"2009","unstructured":"Martinet, L. et al. A regulatory cross-talk between V\u03b39V\u03b42 T lymphocytes and mesenchymal stem cells. Eur. J. Immunol. 39, 752\u2013762 (2009).","journal-title":"Eur. J. Immunol."},{"key":"BFnrclinonc2009169_CR87","first-page":"29","volume":"18","author":"JI Henter","year":"1991","unstructured":"Henter, J. I., Elinder, G. & Ost, A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin. Oncol. 18, 29\u201333 (1991).","journal-title":"Semin. Oncol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T13:24:57Z","timestamp":1685193897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2009.169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,10]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BFnrclinonc2009169"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2009.169","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,10]]}}}